These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21067260)
1. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers. Yu L; Wang L; Chen S Neoplasma; 2011; 58(1):9-13. PubMed ID: 21067260 [TBL] [Abstract][Full Text] [Related]
2. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767 [TBL] [Abstract][Full Text] [Related]
3. Olfactomedin-4 in digestive diseases: A mini-review. Wang XY; Chen SH; Zhang YN; Xu CF World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203 [TBL] [Abstract][Full Text] [Related]
4. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer. Liu W; Rodgers GP Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440 [TBL] [Abstract][Full Text] [Related]
5. Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer. Jaitner S; Pretzsch E; Neumann J; Schäffauer A; Schiemann M; Angele M; Kumbrink J; Schwitalla S; Greten FR; Brandl L; Klauschen F; Horst D; Kirchner T; Jung A J Pathol Clin Res; 2023 Jan; 9(1):73-85. PubMed ID: 36349502 [TBL] [Abstract][Full Text] [Related]
6. Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer. Clemmensen SN; Glenthøj AJ; Heebøll S; Nielsen HJ; Koch C; Borregaard N J Cell Mol Med; 2015 Dec; 19(12):2865-73. PubMed ID: 26416558 [TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma. Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253 [TBL] [Abstract][Full Text] [Related]
8. Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1. Chen L; Li H; Liu W; Zhu J; Zhao X; Wright E; Cao L; Ding I; Rodgers GP Carcinogenesis; 2011 Jul; 32(7):986-94. PubMed ID: 21470957 [TBL] [Abstract][Full Text] [Related]
9. Olfactomedin 4 is a marker for progression of cervical neoplasia. Yu L; He M; Yang Z; Chen G; Li M; Wang L; Chen S Int J Gynecol Cancer; 2011 Feb; 21(2):367-72. PubMed ID: 21270618 [TBL] [Abstract][Full Text] [Related]
10. Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer. Li H; Rodriguez-Canales J; Liu W; Zhu J; Hanson JC; Pack S; Zhuang Z; Emmert-Buck MR; Rodgers GP Am J Pathol; 2013 Oct; 183(4):1329-38. PubMed ID: 24070418 [TBL] [Abstract][Full Text] [Related]
11. Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells. Kobayashi D; Koshida S; Moriai R; Tsuji N; Watanabe N Cancer Sci; 2007 Mar; 98(3):334-40. PubMed ID: 17270022 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling. Guo LL; He ZC; Yang CQ; Qiao PT; Yin GL BMB Rep; 2015 Nov; 48(11):630-5. PubMed ID: 26303970 [TBL] [Abstract][Full Text] [Related]
13. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer. Jang BG; Lee BL; Kim WH Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873 [TBL] [Abstract][Full Text] [Related]
14. Olfactomedin 4 mediation of prostate stem/progenitor-like cell proliferation and differentiation via MYC. Li H; Chaitankar V; Zhu J; Chin K; Liu W; Pirooznia M; Rodgers GP Sci Rep; 2020 Dec; 10(1):21924. PubMed ID: 33318499 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer. Ma H; Tian T; Liang S; Liu X; Shen H; Xia M; Liu X; Zhang W; Wang L; Chen S; Yu L Oncotarget; 2016 Mar; 7(9):10594-605. PubMed ID: 26871282 [TBL] [Abstract][Full Text] [Related]
16. OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic Approach. Valo I; Raro P; Boissard A; Maarouf A; Jézéquel P; Verriele V; Campone M; Coqueret O; Guette C Proteomics; 2019 Nov; 19(21-22):e1800446. PubMed ID: 31318138 [TBL] [Abstract][Full Text] [Related]
17. Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway. Li H; Liu W; Chen W; Zhu J; Deng CX; Rodgers GP Sci Rep; 2015 Nov; 5():16974. PubMed ID: 26581960 [TBL] [Abstract][Full Text] [Related]
18. Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Grover PK; Hardingham JE; Cummins AG Cancer Metastasis Rev; 2010 Dec; 29(4):761-75. PubMed ID: 20878207 [TBL] [Abstract][Full Text] [Related]
19. Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades. Klaas M; Mäemets-Allas K; Heinmäe E; Lagus H; Arak T; Eller M; Kingo K; Kankuri E; Jaks V Cell Mol Life Sci; 2022 Feb; 79(3):157. PubMed ID: 35218417 [TBL] [Abstract][Full Text] [Related]
20. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. Chin KL; Aerbajinai W; Zhu J; Drew L; Chen L; Liu W; Rodgers GP Br J Haematol; 2008 Nov; 143(3):421-32. PubMed ID: 18764868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]